Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 2/20 | 0.40 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | CDC25C | P30307 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 3/20 | 0.38 |
| ▸ | TERT | O14746 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18614709 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRFAAHTRPV1TYR | |
| SCHEMBL18064497 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRFAAHTRPV1TYR | |
| SCHEMBL2015657 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRFAAHTRPV1TYR | |
| SCHEMBL2021152 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRFAAHTRPV1TYR | |
| SCHEMBL2015658 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRFAAHTRPV1TYR | |
| SCHEMBL18614706 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRFAAHTRPV1TYR | |
| SCHEMBL18614617 | 0.95 | TYR (0.43) | ALDH1A1TSHRTYRABHD16AEPHX2 | |
| SCHEMBL18614691 | 0.95 | TYR (0.43) | ALDH1A1TSHRTYRABHD16AEPHX2 | |
| SCHEMBL18614707 | 0.95 | TYR (0.43) | ALDH1A1TSHRTYRABHD16AEPHX2 | |
| SCHEMBL20561502 | 0.95 | TYR (0.43) | ALDH1A1TSHRTYRABHD16AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180334571-A1 | WATER REPELLENT COMBINATIONS | JANSSEN PHARMACEUTICA NV (BE) | 2018-11-22 | — | — | US | disclosed |
| EP-3347421-A1 | WATER REPELLENT COMBINATIONS | Janssen Pharmaceutica N.V. (BE) | 2018-07-18 | — | — | EP | disclosed |
| US-9796665-B2 | Ceramide derivatives having agonistic effects on epidermal cannabinoid receptors, and pharmaceutical or cosmetic composition containing same | NEOPHARM CO., LTD. (KR) | 2017-10-24 | — | — | US | disclosed |
| WO-2017042120-A1 | WATER REPELLENT COMBINATIONS | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-16 | — | — | WO | disclosed |
| US-20160272578-A1 | NOVEL CERAMIDE DERIVATIVES HAVING AGONISTIC EFFECTS ON EPIDERMAL CANNABINOID RECEPTORS, AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING SAME | NEOPHARM CO., LTD. (KR) | 2016-09-22 | — | — | US | disclosed |
| US-8632659-B2 | Paper sizing composition | HERCULES INCORPORATED (US) | 2014-01-21 | — | — | US | disclosed |
| EP-2513373-B1 | PAPER SIZING COMPOSITION | HERCULES INC (US) | 2013-10-09 | — | — | EP | disclosed |
| EP-1299488-B1 | COMPOSITIONS FOR IMPARTING DESIRED PROPERTIES TO MATERIALS | HERCULES INC (US) | 2013-09-04 | — | — | EP | disclosed |
| EP-2513373-A2 | PAPER SIZING COMPOSITION | Hercules Incorporated (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011075633-A2 | PAPER SIZING COMPOSITION | HERCULES INCORPORATED (US) | 2011-06-23 | — | — | WO | disclosed |
| US-20110146926-A1 | Paper Sizing Composition | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT | 2011-06-23 | — | — | US | disclosed |
| US-7317053-B1 | Compositions for imparting desired properties to materials | HERCULES INCORPORATED (US) | 2008-01-08 | — | — | US | disclosed |
| EP-1299488-A2 | COMPOSITIONS FOR IMPARTING DESIRED PROPERTIES TO MATERIALS | HERCULES INCORPORATED (US) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002008514-A2 | METHOD OF MAKING SIZING EMULSION AND SIZING EMULSION | HERCULES INCORPORATED (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2002004133-A2 | COMPOSITIONS FOR IMPARTING DESIRED PROPERTIES TO MATERIALS | HERCULES INCORPORATED (US) | 2002-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160272578-A1 | NOVEL CERAMIDE DERIVATIVES HAVING AGONISTIC EFFECTS ON EPIDERMAL CANNABINOID RECEPTORS, AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING SAME | CNR1, CNR2, CERS2 | ALDH1A1 4586/4885TSHR 1698/4885FAAH 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.